4-2825178-A-G

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2

The NM_001122681.2(SH3BP2):ā€‹c.410A>Gā€‹(p.Asp137Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000133 in 1,581,368 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D137E) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.000033 ( 0 hom., cov: 34)
Exomes š‘“: 0.000011 ( 1 hom. )

Consequence

SH3BP2
NM_001122681.2 missense

Scores

7
12

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 7.41
Variant links:
Genes affected
SH3BP2 (HGNC:10825): (SH3 domain binding protein 2) The protein encoded by this gene has an N-terminal pleckstrin homology (PH) domain, an SH3-binding proline-rich region, and a C-terminal SH2 domain. The protein binds to the SH3 domains of several proteins including the ABL1 and SYK protein tyrosine kinases , and functions as a cytoplasmic adaptor protein to positively regulate transcriptional activity in T, natural killer (NK), and basophilic cells. Mutations in this gene result in cherubism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.13067552).
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0000329 (5/151868) while in subpopulation AMR AF= 0.000327 (5/15272). AF 95% confidence interval is 0.000129. There are 0 homozygotes in gnomad4. There are 3 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 5 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SH3BP2NM_001122681.2 linkuse as main transcriptc.410A>G p.Asp137Gly missense_variant 5/13 ENST00000503393.8
SH3BP2NM_001145856.2 linkuse as main transcriptc.581A>G p.Asp194Gly missense_variant 5/13
SH3BP2NM_001145855.2 linkuse as main transcriptc.494A>G p.Asp165Gly missense_variant 5/13
SH3BP2NM_003023.4 linkuse as main transcriptc.410A>G p.Asp137Gly missense_variant 5/13

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SH3BP2ENST00000503393.8 linkuse as main transcriptc.410A>G p.Asp137Gly missense_variant 5/131 NM_001122681.2 P2P78314-1

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
151868
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000256
AC:
5
AN:
195178
Hom.:
1
AF XY:
0.0000381
AC XY:
4
AN XY:
105056
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000173
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000112
AC:
16
AN:
1429500
Hom.:
1
Cov.:
32
AF XY:
0.0000155
AC XY:
11
AN XY:
708240
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000275
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000366
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000339
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
151868
Hom.:
0
Cov.:
34
AF XY:
0.0000405
AC XY:
3
AN XY:
74156
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000453
ExAC
AF:
0.0000167
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 21, 2024The c.410A>G (p.D137G) alteration is located in exon 5 (coding exon 4) of the SH3BP2 gene. This alteration results from a A to G substitution at nucleotide position 410, causing the aspartic acid (D) at amino acid position 137 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Fibrous dysplasia of jaw Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeDec 18, 2023This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 137 of the SH3BP2 protein (p.Asp137Gly). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with SH3BP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 525199). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SH3BP2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Uncertain
0.042
T
BayesDel_noAF
Benign
-0.18
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.36
T;.;.;T;T;.;.;T;T;.;T
Eigen
Benign
0.027
Eigen_PC
Benign
0.13
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.85
.;.;D;D;D;D;T;.;.;D;D
M_CAP
Uncertain
0.22
D
MetaRNN
Benign
0.13
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.42
T
MutationAssessor
Benign
1.2
L;.;.;.;.;.;.;L;L;.;L
MutationTaster
Benign
0.98
D;D;D;D;D;D
PrimateAI
Benign
0.41
T
PROVEAN
Uncertain
-2.6
D;N;N;D;D;D;N;D;D;D;D
REVEL
Benign
0.19
Sift
Uncertain
0.0030
D;D;D;D;D;D;D;D;D;D;D
Sift4G
Uncertain
0.051
T;D;D;D;D;D;D;T;T;D;T
Polyphen
0.32
B;.;.;.;.;.;.;B;B;.;B
Vest4
0.17
MutPred
0.24
Gain of methylation at K136 (P = 0.0446);Gain of methylation at K136 (P = 0.0446);Gain of methylation at K136 (P = 0.0446);Gain of methylation at K136 (P = 0.0446);Gain of methylation at K136 (P = 0.0446);.;Gain of methylation at K136 (P = 0.0446);Gain of methylation at K136 (P = 0.0446);Gain of methylation at K136 (P = 0.0446);.;Gain of methylation at K136 (P = 0.0446);
MVP
0.89
MPC
0.25
ClinPred
0.45
T
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.33

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs777468144; hg19: chr4-2826905; API